id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-E-3616-0009,FDA,FDA-2017-E-3616,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2020-01-22T05:00:00Z,2020,1,2020-01-22T05:00:00Z,,2020-01-22T14:10:31Z,,0,0,09000064842d4651